pharmalink consulting operations ltd
pharmalink consulting operations ltd Company Information
Company Number
NI611117
Next Accounts
Sep 2025
Shareholders
genpact luxembourg s.a r.l.
Group Structure
View All
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Registered Address
floor 3 adelaide exchange, 24-26 adelaide street, belfast, northern ireland, BT2 8GD
Website
www.pharmalinkconsulting.compharmalink consulting operations ltd Estimated Valuation
Pomanda estimates the enterprise value of PHARMALINK CONSULTING OPERATIONS LTD at £193.8k based on a Turnover of £333.1k and 0.58x industry multiple (adjusted for size and gross margin).
pharmalink consulting operations ltd Estimated Valuation
Pomanda estimates the enterprise value of PHARMALINK CONSULTING OPERATIONS LTD at £170.8k based on an EBITDA of £40.8k and a 4.18x industry multiple (adjusted for size and gross margin).
pharmalink consulting operations ltd Estimated Valuation
Pomanda estimates the enterprise value of PHARMALINK CONSULTING OPERATIONS LTD at £1.6m based on Net Assets of £676.5k and 2.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pharmalink Consulting Operations Ltd Overview
Pharmalink Consulting Operations Ltd is a live company located in belfast, BT2 8GD with a Companies House number of NI611117. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in February 2012, it's largest shareholder is genpact luxembourg s.a r.l. with a 100% stake. Pharmalink Consulting Operations Ltd is a established, micro sized company, Pomanda has estimated its turnover at £333.1k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pharmalink Consulting Operations Ltd Health Check
Pomanda's financial health check has awarded Pharmalink Consulting Operations Ltd a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
4 Weak
Size
annual sales of £333.1k, make it smaller than the average company (£2.9m)
£333.1k - Pharmalink Consulting Operations Ltd
£2.9m - Industry AVG
Growth
3 year (CAGR) sales growth of -44%, show it is growing at a slower rate (7.2%)
-44% - Pharmalink Consulting Operations Ltd
7.2% - Industry AVG
Production
with a gross margin of 41.3%, this company has a comparable cost of product (45%)
41.3% - Pharmalink Consulting Operations Ltd
45% - Industry AVG
Profitability
an operating margin of 12.3% make it more profitable than the average company (5.6%)
12.3% - Pharmalink Consulting Operations Ltd
5.6% - Industry AVG
Employees
with 6 employees, this is below the industry average (23)
6 - Pharmalink Consulting Operations Ltd
23 - Industry AVG
Pay Structure
on an average salary of £32.6k, the company has a lower pay structure (£53.5k)
£32.6k - Pharmalink Consulting Operations Ltd
£53.5k - Industry AVG
Efficiency
resulting in sales per employee of £55.5k, this is less efficient (£126.3k)
£55.5k - Pharmalink Consulting Operations Ltd
£126.3k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Pharmalink Consulting Operations Ltd
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Pharmalink Consulting Operations Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Pharmalink Consulting Operations Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Pharmalink Consulting Operations Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 47.8%, this is a lower level of debt than the average (53.2%)
47.8% - Pharmalink Consulting Operations Ltd
53.2% - Industry AVG
PHARMALINK CONSULTING OPERATIONS LTD financials
Pharmalink Consulting Operations Ltd's latest turnover from December 2023 is £333.1 thousand and the company has net assets of £676.5 thousand. According to their latest financial statements, Pharmalink Consulting Operations Ltd has 6 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Apr 2014 | Apr 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 333,081 | 940,521 | 988,707 | 1,885,844 | 2,126,659 | 2,273,993 | 1,869,124 | 1,241,661 | 712,023 | 311,594 | ||
| Other Income Or Grants | ||||||||||||
| Cost Of Sales | 195,513 | 657,063 | 789,810 | 898,806 | 1,651,227 | 1,800,612 | 1,380,811 | 1,039,619 | 562,612 | 243,049 | ||
| Gross Profit | 137,568 | 283,458 | 198,897 | 987,038 | 475,432 | 473,381 | 488,313 | 202,042 | 149,411 | 68,545 | ||
| Admin Expenses | 96,722 | 238,670 | 152,748 | 897,241 | 374,158 | 363,939 | 399,309 | 52,935 | 92,644 | 76,569 | ||
| Operating Profit | 40,846 | 44,788 | 46,149 | 89,797 | 101,274 | 109,442 | 89,004 | 149,107 | 56,767 | -8,024 | ||
| Interest Payable | 10,722 | 14,763 | 19,114 | 23,210 | 26,560 | 1,157 | ||||||
| Interest Receivable | 47,353 | 85,180 | 60,552 | 2,863 | 10,302 | 21 | ||||||
| Pre-Tax Profit | 77,477 | 115,205 | 87,587 | 69,450 | 85,016 | 108,285 | 89,004 | 149,128 | 56,767 | -8,024 | ||
| Tax | -20,061 | -20,775 | -17,737 | -12,662 | -34,338 | 2,513 | -20,211 | -31,394 | -10,693 | -990 | ||
| Profit After Tax | 57,416 | 94,430 | 69,850 | 56,788 | 50,678 | 110,798 | 68,793 | 117,734 | 46,074 | -9,014 | ||
| Dividends Paid | ||||||||||||
| Retained Profit | 57,416 | 94,430 | 69,850 | 56,788 | 50,678 | 110,798 | 68,793 | 117,734 | 46,074 | -9,014 | ||
| Employee Costs | 195,513 | 495,316 | 709,363 | 789,931 | 1,650,747 | 1,817,887 | 1,397,607 | 561,432 | 242,999 | |||
| Number Of Employees | 6 | 19 | 29 | 33 | 70 | 81 | 71 | 49 | 26 | 17 | ||
| EBITDA* | 40,846 | 44,788 | 46,149 | 154,711 | 248,949 | 109,442 | 96,485 | 161,590 | 85,582 | 11,186 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Apr 2014 | Apr 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 909,520 | 7,481 | 11,613 | 40,428 | 59,637 | 78,976 | ||||||
| Intangible Assets | ||||||||||||
| Investments & Other | ||||||||||||
| Debtors (Due After 1 year) | 1,637 | 4,984 | 2,555 | 3,347 | 3,649 | 3,441 | 1,100 | 1,100 | 547 | |||
| Total Fixed Assets | 1,637 | 4,984 | 2,555 | 3,347 | 913,169 | 3,441 | 7,481 | 12,713 | 41,528 | 60,184 | 78,976 | |
| Stock & work in progress | ||||||||||||
| Trade Debtors | 473,245 | 163,652 | ||||||||||
| Group Debtors | 1,085,949 | 12,322,416 | 8,464,088 | 7,616,450 | 7,226,743 | 3,878,279 | 1,836,350 | 898,973 | 1,236,657 | 649,793 | ||
| Misc Debtors | 207,374 | 20,077 | 212,175 | 211,149 | 223,841 | 18,984 | 39,086 | 42,988 | 6,479 | 21,180 | ||
| Cash | 89,232 | 171,185 | 346,463 | 202,348 | 16,138 | 39,436 | ||||||
| misc current assets | ||||||||||||
| total current assets | 1,293,323 | 12,431,725 | 8,676,263 | 7,827,599 | 7,450,584 | 4,068,448 | 2,221,899 | 1,144,309 | 1,259,274 | 710,409 | 473,245 | 163,652 |
| total assets | 1,294,960 | 12,436,709 | 8,678,818 | 7,830,946 | 8,363,753 | 4,071,889 | 2,221,899 | 1,151,790 | 1,271,987 | 751,937 | 533,429 | 242,628 |
| Bank overdraft | 8 | |||||||||||
| Bank loan | ||||||||||||
| Trade Creditors | 20,547 | 1,882 | 520,509 | 234,222 | ||||||||
| Group/Directors Accounts | 270,614 | 11,265,175 | 7,430,094 | 6,518,180 | 6,902,766 | 3,407,882 | 1,832,159 | 900,877 | 1,159,585 | 729,566 | ||
| other short term finances | ||||||||||||
| hp & lease commitments | 134,746 | 134,746 | 153,963 | 152,986 | 111,258 | |||||||
| other current liabilities | 33,367 | 103,232 | 113,045 | 90,714 | 188,748 | 316,702 | 153,233 | 83,199 | 41,875 | 16,583 | ||
| total current liabilities | 438,735 | 11,503,153 | 7,697,102 | 6,761,880 | 7,202,772 | 3,724,584 | 1,985,392 | 984,076 | 1,222,007 | 748,031 | 520,509 | 234,222 |
| loans | ||||||||||||
| hp & lease commitments | 179,758 | 314,505 | 457,095 | 614,295 | 762,998 | |||||||
| Accruals and Deferred Income | ||||||||||||
| other liabilities | ||||||||||||
| provisions | ||||||||||||
| total long term liabilities | 179,758 | 314,505 | 457,095 | 614,295 | 762,998 | |||||||
| total liabilities | 618,493 | 11,817,658 | 8,154,197 | 7,376,175 | 7,965,770 | 3,724,584 | 1,985,392 | 984,076 | 1,222,007 | 748,031 | 520,509 | 234,222 |
| net assets | 676,467 | 619,051 | 524,621 | 454,771 | 397,983 | 347,305 | 236,507 | 167,714 | 49,980 | 3,906 | 12,920 | 8,406 |
| total shareholders funds | 676,467 | 619,051 | 524,621 | 454,771 | 397,983 | 347,305 | 236,507 | 167,714 | 49,980 | 3,906 | 12,920 | 8,406 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Apr 2014 | Apr 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Operating Profit | 40,846 | 44,788 | 46,149 | 89,797 | 101,274 | 109,442 | 89,004 | 149,107 | 56,767 | -8,024 | ||
| Depreciation | 64,914 | 147,675 | 7,481 | 12,483 | 28,815 | 19,210 | 23,997 | 31,628 | ||||
| Amortisation | ||||||||||||
| Tax | -20,061 | -20,775 | -17,737 | -12,662 | -34,338 | 2,513 | -20,211 | -31,394 | -10,693 | -990 | ||
| Stock | ||||||||||||
| Debtors | -11,052,517 | 3,668,659 | 847,872 | 376,713 | 3,553,529 | 2,025,268 | 933,475 | -302,275 | 572,163 | 508,421 | 310,140 | 163,652 |
| Creditors | -20,547 | 18,665 | -232,340 | 286,287 | 234,222 | |||||||
| Accruals and Deferred Income | -69,865 | -9,813 | 22,331 | -98,034 | -127,954 | 163,469 | 70,034 | 41,324 | 25,292 | 16,583 | ||
| Deferred Taxes & Provisions | ||||||||||||
| Cash flow from operations | 11,003,437 | -3,654,459 | -797,129 | -332,698 | -3,466,872 | -1,749,844 | 453,248 | -453,317 | -713,982 | |||
| Investing Activities | ||||||||||||
| capital expenditure | ||||||||||||
| Change in Investments | ||||||||||||
| cash flow from investments | ||||||||||||
| Financing Activities | ||||||||||||
| Bank loans | ||||||||||||
| Group/Directors Accounts | -10,994,561 | 3,835,081 | 911,914 | -384,586 | 3,494,884 | 1,575,723 | 931,282 | -258,708 | 430,019 | 729,566 | ||
| Other Short Term Loans | ||||||||||||
| Long term loans | ||||||||||||
| Hire Purchase and Lease Commitments | -134,747 | -161,807 | -156,223 | -106,975 | 874,256 | |||||||
| other long term liabilities | ||||||||||||
| share issue | ||||||||||||
| interest | 36,631 | 70,417 | 41,438 | -20,347 | -16,258 | -1,157 | 21 | |||||
| cash flow from financing | -11,092,677 | 3,743,691 | 797,129 | -511,908 | 4,352,882 | 1,574,566 | 931,282 | -258,687 | 430,019 | 734,080 | ||
| cash and cash equivalents | ||||||||||||
| cash | -89,232 | 89,232 | -171,185 | -175,278 | 144,115 | 186,210 | -23,298 | 39,436 | ||||
| overdraft | 8 | |||||||||||
| change in cash | -89,240 | 89,232 | -171,185 | -175,278 | 144,115 | 186,210 | -23,298 | 39,436 |
pharmalink consulting operations ltd Credit Report and Business Information
Pharmalink Consulting Operations Ltd Competitor Analysis
Perform a competitor analysis for pharmalink consulting operations ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in BT2 area or any other competitors across 12 key performance metrics.
pharmalink consulting operations ltd Ownership
PHARMALINK CONSULTING OPERATIONS LTD group structure
Pharmalink Consulting Operations Ltd has no subsidiary companies.
Ultimate parent company
GENPACT LUXEMBOURG SARL
#0164708
1 parent
PHARMALINK CONSULTING OPERATIONS LTD
NI611117
pharmalink consulting operations ltd directors
Pharmalink Consulting Operations Ltd currently has 2 directors. The longest serving directors include Mr Lester D'Souza (Jan 2020) and Mr Stuart Bridges (Jun 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Lester D'Souza | England | 50 years | Jan 2020 | - | Director |
| Mr Stuart Bridges | United Kingdom | 61 years | Jun 2022 | - | Director |
P&L
December 2023turnover
333.1k
-65%
operating profit
40.8k
-9%
gross margin
41.4%
+37.04%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
676.5k
+0.09%
total assets
1.3m
-0.9%
cash
0
-1%
net assets
Total assets minus all liabilities
pharmalink consulting operations ltd company details
company number
NI611117
Type
Private limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
February 2012
age
13
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
FORVIS MAZARS LLP
address
floor 3 adelaide exchange, 24-26 adelaide street, belfast, northern ireland, BT2 8GD
Bank
-
Legal Advisor
-
pharmalink consulting operations ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pharmalink consulting operations ltd.
pharmalink consulting operations ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PHARMALINK CONSULTING OPERATIONS LTD. This can take several minutes, an email will notify you when this has completed.
pharmalink consulting operations ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
